Swiercz Jakub M, Worzfeld Thomas, Offermanns Stefan
Institute of Pharmacology, University of Heidelberg, Im Neuenheimer Feld 366, 69120 Heidelberg, Germany.
J Biol Chem. 2008 Jan 25;283(4):1893-901. doi: 10.1074/jbc.M706822200. Epub 2007 Nov 19.
Sema4D-induced activation of plexin-B1 has been reported to evoke different and sometimes opposing cellular responses. The mechanisms underlying the versatility of plexin-B1-mediated effects are not clear. Plexin-B1 can associate with the receptor tyrosine kinases ErbB-2 and Met. Here we show that Sema4D-induced activation and inactivation of RhoA require ErbB-2 and Met, respectively. In breast carcinoma cells, Sema4D can have pro- and anti-migratory effects depending on the presence of ErbB-2 and Met, and the exchange of the two receptor tyrosine kinases is sufficient to convert the cellular response to Sema4D from pro- to anti-migratory and vice versa. This work identifies a novel mechanism by which plexin-mediated signaling can be regulated and explains how Sema4D can exert different biological activities through the differential association of its receptor with ErbB-2 and Met.
据报道,Sema4D诱导的丛状蛋白B1激活可引发不同且有时相反的细胞反应。丛状蛋白B1介导效应的多样性背后的机制尚不清楚。丛状蛋白B1可与受体酪氨酸激酶ErbB-2和Met结合。在这里,我们表明,Sema4D诱导的RhoA激活和失活分别需要ErbB-2和Met。在乳腺癌细胞中,Sema4D根据ErbB-2和Met的存在情况可产生促迁移和抗迁移作用,并且这两种受体酪氨酸激酶的交换足以将细胞对Sema4D的反应从促迁移转变为抗迁移,反之亦然。这项工作确定了一种调节丛状蛋白介导信号传导的新机制,并解释了Sema4D如何通过其受体与ErbB-2和Met的差异结合发挥不同的生物学活性。